Sistema de Salut de Catalunya
Institut Català de la Salut
[Zanelli S] Laboratoire Analyse, Géométrie et Applications, Université Sorbonne Paris Nord, Paris, France. Axelife, Paris, France. [Agnoletti D] Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico Sant’Orsola, Bologna, Italy. Cardiovascular Medicine Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. [Alastruey J] Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King’s College London, London, United Kingdom. [Allen J] Research Centre for Intelligent Healthcare, Coventry University, Coventry, United Kingdom. Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom. [Bianchini E] Institute of Clinical Physiology, Italian National Research Council (CNR), Pisa, Italy. [Bikia V] Stanford University, Stanford, California, United States. Swiss Federal Institute of Technology of Lausanne, Lausanne, Switzerland. [Guala A] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER-CV, Instituto de Salud Carlos III, Madrid, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-01-21T09:50:30Z
2025-01-21T09:50:30Z
2024-12-30
Ageing; Arterial stiffness; Cardiovascular
Envejecimiento; Rigidez arterial; Cardiovascular
Envelliment; Rigidesa arterial; Cardiovascular
Vascular ageing (vascular ageing) is the deterioration of arterial structure and function which occurs naturally with age, and which can be accelerated with disease. Measurements of vascular ageing are emerging as markers of cardiovascular risk, with potential applications in disease diagnosis and prognosis, and for guiding treatments. However, vascular ageing is not yet routinely assessed in clinical practice. A key step towards this is the development of technologies to assess vascular ageing. In this Roadmap, experts discuss several aspects of this process, including: measurement technologies; the development pipeline; clinical applications; and future research directions. The Roadmap summarises the state of the art, outlines the major challenges to overcome, and identifies potential future research directions to address these challenges.
This work was supported by COST Action CA18216 VascAgeNet, supported by COST (European Cooperation in Science and Technology, www.cost.eu). P H C acknowledges funding from the British Heart Foundation (FS/20/20/34626). Guala A has received funding from 'la Caixa' Foundation (LCF/BQ/PR22/11920008).
Article
Versió publicada
Anglès
Sistema cardiovascular - Malalties; Sistema cardiovascular - Envelliment; Tecnologia mèdica; PHENOMENA AND PROCESSES::Physiological Phenomena::Growth and Development::Aging; DISEASES::Cardiovascular Diseases; PUBLIC HEALTH::Environmental Health::Environmental Engineering::Technological Development::Technology; FENÓMENOS Y PROCESOS::fenómenos fisiológicos::crecimiento y desarrollo::envejecimiento; ENFERMEDADES::enfermedades cardiovasculares; SALUD PÚBLICA::salud ambiental::ingeniería ambiental::desarrollo tecnológico::tecnología
IOP Publishing
Physiological Measurement;45(12)
https://doi.org/10.1088/1361-6579/ad548e
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]
